Nichi-Iko Looks To File For Interchangeable Infliximab In US Next Year

 
• By Aidan Fry
  
TrainTracks
Achieving An Interhangeability Designation For Infliximab Would Allow Pharmacy-Level Switching To Nichi-Iko's Infliximab In The US • Source: Shutterstock

More from Biosimilars

More from Products